Results 131 to 140 of about 3,775 (204)

Burden of Clostridioides difficile Infection and Risk Factors for Recurrences in an Italian Tertiary Care University Hospital: A Prospective Observational Study. [PDF]

Antibiotics (Basel)
Gagliano MC, D'Agati G, Medaglia AA, Pipitò L, Catania B, Conti C, Tuttolomondo A, Cefalù AB, Cammà C, Scichilone N, Licata A, Barbagallo M, Immordino R, Virruso R, Giammanco GM, Cascio A.   +15 more
europepmc   +1 more source

Impact of admission screening on <i>Clostridioides difficile</i> infection rates in a hematology-oncology and hematopoietic cell transplant unit. [PDF]

Infect Control Hosp Epidemiol
Lucky CW, Thotapalli L, Rusie LK, Rhee Y, Schoeny ME, Kraut NA, Seguin A, Stein BD, Rodriguez RI, Hayden MK, Lin MY.   +10 more
europepmc   +1 more source

Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital. [PDF]

Med Sci Monit
Drobnik J, Pobrotyn P, Grata-Borkowska U, Madziarska K, Baran M.   +4 more
europepmc   +1 more source

<i>In Vitro</i> Activity of Sulfamethoxazole-Trimethoprim, Amikacin, Oxazolidinones, Fluoroquinolones and Fidaxomicin against Isolates of <i>Nocardia</i>. [PDF]

ACS Omega
Wang C, Shi Y, Wei M, Yan J, Long S, Jiang G, Zhao Y, Huang H, Gu L, Yang X, Li H, Wang G.   +11 more
europepmc   +1 more source

Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

JAMA Netw Open
McDonald EG, Butler-Laporte G, Brophy JM, Elsayed S, Frenette C, Huseen I, Loo VG, Moran K, Coburn B, Hota SS, Longtin Y, Kong LY, Muller MP, Steiner TS, Valiquette L, Daneman N, Daley P, Nott C, MacFadden DR, Kandel CE, Chen Y, Perez-Patrigeon S, Lee TC, TAPER-V Team.   +23 more
europepmc   +1 more source

New drugs: Fidaxomicin

Australian Prescriber, 2013
openaire   +1 more source

Genomic evolution and re-emergence of a multidrug-resistant <i>Clostridioides difficile</i> RT027 clone with reduced vancomycin susceptibility driving a prolonged hospital outbreak. [PDF]

Emerg Microbes Infect
Isidro J, Dionísio F, Alves F, Almeida S, Santos C, Santos MM, Reis E, Oliveira JR, Gomes JP, Oleastro M.   +9 more
europepmc   +1 more source

Clinical Outcomes of Metronidazole Monotherapy Versus Metronidazole Plus <i>Clostridium butyricum</i> MIYAIRI 588 Combination Therapy in Non-Severe <i>Clostridioides difficile</i> Infection: A Retrospective Cohort Study. [PDF]

BioTech (Basel)
Yamada Y, Nemoto M, Miyazaki M, Hirata H, Hosogoe K, Nakashima A, Kushima H, Ishii H, Imakyure O.   +8 more
europepmc   +1 more source

What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients? [PDF]

Antimicrob Steward Healthc Epidemiol
Raja K, Acbo A, Jimenez HR, Silverman D, Golia A, Ford AJ, Nori P.   +6 more
europepmc   +1 more source

Newer Therapeutics to Selectively Kill <i>Clostridioides difficile</i> and Restore the Microbiome. [PDF]

Infect Dis Rep
Granata G, Petrosillo N.
europepmc   +1 more source